Racivir Completed Phase 1 Trials for Human Immunodeficiency Virus (HIV) Infections Prevention

IndicationsStatusPurposePhase
CompletedPrevention1
clinicaltrials.gov IdentifierTitleDrugs
NCT00040300A 14-Day Study of Racivir When Used in Combination in HIV-Infected Males